🇺🇸 FDA
Pipeline program

Firibastat

QGC001-3QG1

Phase 3 small_molecule completed

Quick answer

Firibastat for Hypertension is a Phase 3 program (small_molecule) at Quantum Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Quantum Biopharma
Indication
Hypertension
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials